Minwei Dai

2 months ago | mondaq.com | Brian Johnson |Minwei Dai

On March 24, 2025, the United States Patent and Tradmark Office("USPTO") issued a new Memorandum providing guidance ondiscretionary denials (or "Fintiv denials") forinter partes review ("IPR") challenges based onco-pending patent litigation. Notably, the 2025 Memo states thatthe Patent Trial and Appeal Board ("PTAB") will againapply the Fintiv factors when there is a parallelproceeding before the International Trade Commission("ITC").